Division of Nephrology, School of Medicine, Indiana University, Indianapolis, Indiana.
Pennington Biomedical Research Institute, Louisiana State University, Baton Rouge, Louisiana.
Am J Kidney Dis. 2022 Dec;80(6):783-793. doi: 10.1053/j.ajkd.2022.06.007. Epub 2022 Oct 21.
The National Kidney Foundation (NKF) and The Obesity Society (TOS) cosponsored a multispecialty international workshop in April 2021 to advance the understanding and management of obesity in adults with chronic kidney disease (CKD). The underlying rationale for the workshop was the accumulating evidence that obesity is a major contributor to CKD and adverse outcomes in individuals with CKD, and that effective treatment of obesity, including lifestyle intervention, weight loss medications, and metabolic surgery, can have beneficial effects. The attendees included a range of experts in the areas of kidney disease, obesity medicine, endocrinology, diabetes, bariatric/metabolic surgery, endoscopy, transplant surgery, and nutrition, as well as patients with obesity and CKD. The group identified strategies to increase patient and provider engagement in obesity management, outlined a collaborative action plan to engage nephrologists and obesity medicine experts in obesity management, and identified research opportunities to address gaps in knowledge about the interaction between obesity and kidney disease. The workshop's conclusions help lay the groundwork for development of an effective, scientifically based, and multidisciplinary approach to the management of obesity in people with CKD.
美国肾脏基金会(NKF)和肥胖学会(TOS)于 2021 年 4 月共同主办了一次多学科国际研讨会,旨在提高对慢性肾脏病(CKD)成人肥胖的认识和管理水平。研讨会的基本原理是,越来越多的证据表明肥胖是 CKD 和 CKD 患者不良结局的主要原因,而有效的肥胖治疗,包括生活方式干预、减肥药物和代谢手术,都可以产生有益的效果。与会者包括肾脏病、肥胖医学、内分泌学、糖尿病、减重/代谢手术、内窥镜检查、移植手术和营养等领域的一系列专家,以及肥胖和 CKD 患者。该小组确定了增加患者和医务人员参与肥胖管理的策略,概述了一项合作行动计划,以让肾脏病专家和肥胖医学专家参与肥胖管理,并确定了研究机会,以解决肥胖与肾脏疾病相互作用方面知识差距的问题。该研讨会的结论为制定一种有效的、基于科学的、多学科的 CKD 患者肥胖管理方法奠定了基础。